$MGNC
Mag Magna Corp

2024 Q3 Form 10-Q Financial Statement

#000194986424000019 Filed on September 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $5.293K
YoY Change
Cost Of Revenue $4.400K
YoY Change
Gross Profit $893.00 $0.00
YoY Change
Gross Profit Margin 16.87%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $19.32K $7.424K
YoY Change 160.25%
Operating Profit -$14.03K -$7.424K
YoY Change 88.95%
Interest Expense $2.00 $5.00
YoY Change -60.0%
% of Operating Profit
Other Income/Expense, Net $2.00 $5.00
YoY Change -60.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$14.03K -$7.419K
YoY Change 89.06%
Net Earnings / Revenue -264.99%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 5.829M shares
Diluted Shares Outstanding 5.829M shares 4.500M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $1.500K
Receivables
Other Receivables
Total Short-Term Assets $1.500K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $76.94K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $76.94K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.500K
Total Long-Term Assets $76.94K
Total Assets $78.44K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.22K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $123.5K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $123.5K
Total Long-Term Liabilities
Total Liabilities $123.5K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$82.80K
YoY Change
Common Stock $37.73K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$45.07K -$20.84K
YoY Change
Total Liabilities & Shareholders Equity $78.44K
YoY Change

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$14.03K -$7.419K
YoY Change 89.06%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$562.00 -$6.635K
YoY Change -91.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $562.00 $6.635K
YoY Change -91.53%
NET CHANGE
Cash From Operating Activities -$562.00 -$6.635K
Cash From Investing Activities
Cash From Financing Activities $562.00 $6.635K
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$562.00 -$6.635K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
usd
CY2023Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
CY2023Q3 us-gaap Deferred Income Addition
DeferredIncomeAddition
usd
CY2024Q3 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
usd
CY2023Q3 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2024Q3 us-gaap Interest Paid
InterestPaid
usd
CY2023Q3 us-gaap Interest Paid
InterestPaid
usd
CY2024Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1500 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
73600 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1500 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
73600 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76937 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13172 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
76937 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
13172 usd
CY2024Q3 us-gaap Assets
Assets
78437 usd
CY2024Q2 us-gaap Assets
Assets
86772 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
12224 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12447 usd
CY2024Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
5352 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
105931 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
105369 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
123507 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
117816 usd
CY2024Q3 us-gaap Liabilities
Liabilities
123507 usd
CY2024Q2 us-gaap Liabilities
Liabilities
117816 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5829047 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5829047 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
5829 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5829 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31897 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31897 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82796 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68770 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-45070 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-31044 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78437 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86772 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4400 usd
CY2024Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
893 usd
CY2024Q3 us-gaap Revenues
Revenues
5293 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19321 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7424 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
19321 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7424 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14028 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7424 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
2 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
5 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-14026 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7419 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5829047 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4500000 shares
CY2023Q2 us-gaap Shares Outstanding
SharesOutstanding
4500000 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-13417 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7419 usd
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
4500000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-20836 usd
CY2024Q2 us-gaap Shares Outstanding
SharesOutstanding
5829047 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-31044 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-14026 usd
CY2024Q3 us-gaap Shares Outstanding
SharesOutstanding
5829047 shares
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-45070 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-14026 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7419 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2335 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
784 usd
CY2024Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6000 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
223 usd
CY2024Q3 us-gaap Deferred Income Addition
DeferredIncomeAddition
5352 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-562 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6635 usd
CY2024Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11209 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6640 usd
CY2024Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
10647 usd
CY2023Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
562 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6635 usd
CY2024Q3 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
66100 usd
CY2024Q3 none Accumulated Deficit
AccumulatedDeficit
82796 usd
CY2024Q3 none Netloss
Netloss
14026 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
562 usd
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_z55m0gq8Wysb" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_863_zXDPlTeUJtOf">Use of Estimates</span></i></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
105931 usd
CY2024 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1329047 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q3 us-gaap Advances Fair Value Disclosure
AdvancesFairValueDisclosure
13905 usd

Files In Submission

Name View Source Status
0001949864-24-000019-index-headers.html Edgar Link pending
0001949864-24-000019-index.html Edgar Link pending
0001949864-24-000019.txt Edgar Link pending
0001949864-24-000019-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
maga10q_07312024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20240731.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20240731_cal.xml Edgar Link unprocessable
none-20240731_def.xml Edgar Link unprocessable
none-20240731_pre.xml Edgar Link unprocessable
none-20240731_lab.xml Edgar Link unprocessable
maga10q_07312024_htm.xml Edgar Link completed